The neuregulin-1 gene (NRG1) at chromosome 8p21-22 has been implicated as a schizophrenia susceptibility gene in Icelandic, Scottish, Irish and mixed UK populations. The shared ancestry between these populations led us to investigate the NRG1 polymorphisms and appropriate marker haplotypes for linkage and/or association to schizophrenia in the Irish study of high-density schizophrenia families (ISHDSF). Neither single-point nor multipoint linkage analysis of NRG1 markers gave evidence for linkage independent of our preexisting findings telomeric on 8p. Analysis of linkage disequilibrium (LD) across the 252 kb interval encompassing the 7 marker core Icelandic/Scottish NRG1 haplotype revealed two separate regions of modest LD, comprising markers SNP8NRG255133, SNP8NRG249130 and SNP8NRG243177 (telomeric) and microsatellites 478B14-428, 420M9-1395, D8S1810 and 420M9-116I12 (centromeric). From single marker analysis by TRANSMIT and FBAT we found no evidence for association with schizophrenia for any marker. Haplotype analysis for the three SNPs in LD region 1 and, separately, the four microsatellites in LD region 2 (analyzed in overlapping 2-marker windows), showed no evidence for overtransmission of specific haplotypes to affected individuals. We therefore conclude that if NRG1 does contain susceptibility alleles for schizophrenia, they impact quite weakly on risk in the ISHDSF.
Schizophrenia (MIM 181500) is a common and serious psychiatric disorder with a lifetime prevalence of 0.5-1% worldwide. Symptoms of the disease include delusions and hallucinations (psychotic symptoms), disordered thought, blunted emotions, and cognitive impairment of memory, attention and executive function. Family, twin and adoption studies show consistent evidence of a substantial genetic component in schizophrenia, in conjunction with environmental and developmental factors. 1 It is generally assumed that the genetic component results from variants within, or close to, multiple 'susceptibility genes', which influence the function and/or expression of the molecules they encode and thus perturb neurobiological pathways.
A number of whole genome scans and subsequent meta-analyses have reported consistent evidence for linkage of schizophrenia to chromosome 8p22-11 (SCZD6, MIM 603013). [2] [3] [4] [5] [6] [7] [8] [9] [10] As has been noted before, the candidate region varies between studies, possibly indicating multiple susceptibility loci within this interval. 6, 7 The recent rapid development of highdensity SNP maps and databases as an adjunct to the human genome sequence have enabled regions of replicated linkage to schizophrenia to be examined more closely for gene variants associated with disease. In this way the gene neuregulin-1 (NRG1), on chromosome 8p21-12, has been implicated as a schizophrenia susceptibility gene in Icelandic and Scottish populations, 8, 11 and more recently in an outbred North European population. 12 The NRG1 gene lies 10-30 cM centromeric to most previously reported linkage on 8p.
NRG1 is a functional candidate for involvement in schizophrenia, as it is present in glutamatergic synaptic vesicles, and affects regulation of NMDAreceptor expression by activating ErbB receptors. 8, 13 NRG1 is important in neurodevelopment, promoting neuronal migration and cellular differentiation, and may also modulate synaptic plasticity by mediating signaling cascades at postsynaptic densities. 13 In addition, an NRG1 hypomorphic mouse has reduced levels of NMDA receptors and displays impaired sensorimotor gating, a phenotype that has been associated clinically with schizophrenia in humans. 8 Stefansson et al 8 reported association of schizophrenia with genetic variants in the 5 0 portion of NRG1, which is located within their linkage peak in a large sample of multigenerational Icelandic families. This association with NRG1 was also found in a case/ control sample. 8 Three 'at-risk' haplotypes were identified (Hap A, B, C), sharing a 290-kb core haplotype of five SNPs and two microsatellite markers that showed an estimated frequency of 7.5% in the general population and 15.4% among schizophrenic patients (P ¼ 6.7 Â 10
À6
). These results were subsequently replicated in a Scottish casecontrol study 11 and the centromeric end of Hap B was recently found to confer risk for schizophrenia in an Irish case-control study by Corvin et al.
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In contrast to the Icelandic linkage evidence centred near NRG1, our own Irish Study of highdensity schizophrenia families (ISHDSF) generated a linkage signal B20 cM distal to NRG1. 15 Although the linkage evidence in the ISHDSF did not directly implicate the region near NRG1, the shared ancestry between the Icelandic, Scottish and Irish populations prompted us to investigate key NRG1 polymorphisms and appropriate marker haplotypes for linkage and/or association to schizophrenia in the ISHDSF. 16 The original linkage of schizophrenia to 8p in the ISHDSF generated a maximum two-point heterogeneity lod score (HLOD) of 2.52 at D8S1715, a multipoint HLOD of 2.34 close to D8S258, and broad multipoint nonparametric linkage with peaks (NPL Z-score ¼ 2.51) near D8S1731 and D8S298. 15 Narrow, intermediate and broad diagnostic categories (see Materials and methods) each gave support for linkage to 8p22-21.
Stefansson et al 8 reported the NRG1 'at-risk' haplotype to consist of seven markers that could be identified or tagged by only three of those markers, one SNP (SNP8NRG221533) and two microsatellites (478B14-848 and 420M9-1395). In an attempt to replicate these findings in the ISHDSF, we have genotyped the three markers tagging the 'at-risk' haplotype, two other SNPs from the extended 7 marker haplotype that showed the highest singlepoint association with schizophrenia in the Scottish sample (SNP8NRG241930 and SNP8NRG243177) 11 and two additional microsatellites in intron 1, D8S1810 and 420M9-116I12. These last two markers were recently shown to form part of a separate NRG1 haplotype associated with schizophrenia in an Irish case-control study, 14 which overlaps Icelandic/Scottish Hap B and is called Hap D (markers 420M9-1395/ D8S1810/420M9-116I12). In fact, the two marker overlap with Hap B (420M9-1395/D8S1810) conferred the highest risk in the Irish case-control study and was called Hap B IRE . 14 We analyzed the NRG1 marker data for linkage and/ or association to schizophrenia in the ISHDSF. Singlepoint nonparametric linkage analysis gave no significant results across all three diagnostic categories D2-D8 (data not shown). Multipoint analysis was conducted using all seven NRG1 markers and flanking microsatellites D8S137 and D8S283, for which data had previously been generated. 15 These markers were included to enable clearer distinction of haplotypes identical by descent within families. Suggestive evidence for linkage was observed peaking at SNP8NRG243177 (NPL Z score ¼ 1.75, P ¼ 0.04). However, a re-analysis of linkage incorporating the NRG1 genotypes into our existing genome scan data, 17 indicated that the linkage signal from NRG1 is not distinct from, and does not shift, the original peak centred near LPL and D8S258, and is therefore likely a reflection of the added information content over the region from the NRG1 genotypes ( Figure 1 ).
Computational analysis of the genomic interval embraced by our study (SNP8NRG221533 to 420M9-116I12) showed the region to span B252 kb, encompassing the core Icelandic/Scottish NRG1 haplotype segment (SNP8NRG221132 to 420M9-1395). 11 Intermarker linkage disequilibrium (LD) analysis revealed two separate regions of modest LD within the ISHDSF. 18 Region 1 consisted of markers SNP8 NRG255133, SNP8NRG249130 and SNP8NRG243177 (telomeric, intron 1), while region 2 contained microsatellites 478B14-848, 420M9-1395, D8S1810 and 420M9-116I12 (centromeric, intron 1). These results are shown graphically in Figure 2a with corresponding values in Figure 2b . They are in striking contrast to the single haplotype block initially reported in the Icelandic and Scottish populations. 8, 11 Due to the low LD (D 0 ¼ 0.13-0.26) in our sample between the three SNPs (region 1) and four microsatellites (region 2), testing for disease association with the entire 7 marker haplotype did Figure 1 Graphical representation of multipoint linkage analysis across 8p in the ISHDSF, before and after incorporation of NRG1 marker data. The NRG1 locus lies B60 cM from 8pter.
No major role for NRG1 in schizophrenia in the ISHDSF DL Thiselton et al not appear to be appropriate. Instead, we investigated haplotypes within the two areas of modest LD (D 0 ¼ 0.52-0.78) comprising regions 1 and 2, separately.
No significant evidence for association of any single marker with disease was found, using either TRANS-MIT 19 or FBAT 20 (Table 1a and 1b). In particular, the putative risk-associated alleles in the Icelandic/ Scottish populations 8, 11 and the recent Irish casecontrol study 14 showed no evidence of overtransmission in the ISHDSF. The allele frequencies for the three SNPs in the ISHDSF were similar to those previously reported 8, 11, 12, 14 (data not shown). The frequency of the Icelandic/Scottish partial 'atrisk' haplotype C-G-T for SNPs 221533-241930-243177 (LD region 1) was 0.34 in our sample, making it the most common haplotype for these three markers. However, we found no evidence for association with any of the eight possible three SNP haplotypes in our sample, under any diagnostic category (Table 1a ). The microsatellites in LD region 2 were analysed in sliding 2 marker windows. These two marker haplotypes were recoded as single alleles based on the haplotypes generated for each individual by Simwalk 2.0. 21 We recoded the haplotypes to reduce the computational time (in that haplotype generation for each run is the rate-limiting step) with all rare haplotypes of frequency o1% in the sample recoded as one allele. Extensive haplotype diversity was noted for each of the microsatellite pairs in our sample, reflecting the modest underlying LD ( Figure  2b) , with between 5% (for marker pair 478B14-848/ 420M9-1395) and 11% (for marker pair D18S1810/ 420M9-116I112) of haplotypes falling into the rare category. No significant evidence for association with disease was found for any two microsatellite marker haplotype. Similar analysis of the multimarker SNP and microsatellite haplotypes using FBAT gave no evidence for association under either additive, dominant or recessive inheritance models (data not shown).
Finally, we have recently found that stratified linkage analysis of the IHSDSF, conditioned on the DTNBP1 high-risk haplotype on chromosome 6p, 22 has a profound effect on the linkage evidence on 8p (Webb BT et al, unpublished observations). We therefore analysed the NRG1 markers in the stratified sample for any detectable association of NRG1 variants with schizophrenia in either subset. No significant results were obtained (data not shown).
To summarise, our study of NRG1 detects neither evidence for a linkage signal independent of our previously reported 8p peak, evidence for association with the core haplotype reported in the Icelandic or Scottish samples, evidence for association with the atrisk haplotype in an independent Irish case-control sample, nor evidence for association of a different haplotype in the ISHDSF sample. Multipoint nonparametric analyses of the NRG1 markers in combination with the existing ISHDSF chromosome 8 data suggest that any observed increase in NPLZ score is due to increased information content in the region, and not to a separate signal derived from NRG1.
More importantly, LD studies of this region of NRG1 generate a different picture in the ISHDSF to that initially reported in the Icelandic/Scottish studies. 8, 11 We observe two distinct regions of relatively modest LD encompassing the three SNPs at the distal and the four microsatellites at the proximal end of this interval. This makes direct replication of the analyses from the Icelandic/Scottish samples difficult in the ISHDSF. Since allele frequencies are similar in all three samples, the effect of allele frequencies on pairwise LD measurements 23 does not explain the differences in LD observed. However, a similar 'two block' LD pattern over this region of NRG1 has recently been confirmed by Corvin et al 14 to exist in their independent Irish case-control sample, and also in fact to hold true in the Icelandic and Scottish case samples.
TRANSMIT and FBAT analyses of the NRG1 marker data treated as two separate haplotype regions reveal no evidence for overtransmission or association of 
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No major role for NRG1 in schizophrenia in the ISHDSF DL Thiselton et al either individual alleles of these markers or the corresponding portion of the Icelandic core haplotype. For example, when considering the distal three SNPs, the partial haplotype overlapping with the Icelandic core haplotype is the most common in our sample. Thus, our lack of association is not due to small numbers of this haplotype observed. Similarly, there is no evidence for association of the partial Estimation of the power of our family-based sample to detect the original association between NRG1 and schizophrenia is a complex problem for several reasons. First, our sample of high-density families differs from those used in the prior positive reports (all case/controls). Second, due to the very low LD values we observe between the SNP and microsatellite marker clusters, we did not analyze the 7 marker haplotype significantly associated in the Icelandic and Scottish samples. We therefore utilized the Genetic Power Calculator 24 under the option 'TDT for discrete traits' making, in the process, several plausible assumptions. As our results are based on conservative analyses (one affected individual per nuclear family per pedigree), the number of families included in our study can be reduced to an equal number of trios. As we did not analyze the original 7 marker Icelandic core haplotype (relative risk 2. 2 8 ) as a single entity, but in subsections, we modeled power using a lower relative risk of 2.0. We used 0.25, the frequency of the associated Icelandic 5 marker SNP haplotype, 11 for the marker allele and 0.20 for the high risk allele frequency (ie assuming that 80% of highrisk haplotypes have the high risk allele on them) as a conservative estimate of the effect detectable by our analyses. This calculation indicates that we had 88% power to detect an effect of this size at a significance level of 0.05. While this is certainly only an approximation, it suggests that our sample had adequate power to detect an effect similar to that reported by Stefansson et al. 8, 11 The lack of association in our study of the at-risk haplotype (Hap D or HapB IRE ), or different version thereof, discovered in an Irish case-control sample, 14 is similarly intriguing. The frequency of these haplotypes in the ISHDSF family sample, based on founders, is identical (for Hap D, 7.3%) and very close to (for Hap B IRE , 18.3 vs 19.4%) those of the cases in the case-control study, 14 but neither haplotype appears to confer risk for schizophrenia in the ISHDSF.
Our results may not be so surprising, however, given that the linkage signal on 8p in our study sample is located B20 cM distal to NRG1. Studying the segregation of markers in large multigenerational families by the candidate gene approach will only detect linkage if a gene (or genes) of at least moderate effect is segregating in at least a proportion of the families. Families with higher numbers of affected subjects such as those comprising our sample are also more likely to display intrafamilial heterogeneity. 25 Stefansson et al 8 noted that the contribution of their NRG1 core haplotype to the familial risk of schizophrenia was small, and did not fully explain the linkage results they obtained for this region. They do acknowledge that there may be other schizophrenia susceptibility genes in the 8p region contributing to the linkage evidence, and/or other at-risk alleles/ haplotypes of NRG1. We conclude that if NRG1 does contain susceptibility alleles for schizophrenia, their contribution to disease risk is relatively minor in the ISHDSF.
Materials and methods

Subjects
The ISHDSF sample consists of 270 high-density schizophrenia families with 1425 individuals available for genotyping. 26 All participating individuals gave appropriate informed consent to the study. The sample was divided into three diagnostic categories for analysis purposes, ranging from narrow to broad. Briefly, D2 (narrow) includes schizophrenia, pooroutcome schizoaffective disorder and simple schizophrenia, D5 (intermediate) includes the D2 affecteds plus schizotypal personality disorder and all other nonaffective psychotic disorders, while D8 (broad) additionally includes mood-incongruent and moodcongruent psychotic affective illness, and paranoid, avoidant and schizoid personality disorders. The diagnoses up to the D8 category occur significantly more often in the relatives of schizophrenics. For the purpose of assessing vertical and horizontal transmission information, the number of patients (D2-D8) with both parents was 110, with one parent was 194, with no parents was 420, and for those patients with no parents, 338 had additional siblings for inclusion in the family-based association study.
Genotyping PCR primers were designed manually for the NRG1 polymorphisms used for genotyping from the sequences available in the deCODE Genetics database (http://www.decode.com/nrg1/markers/) and obtained from The Genome Database for D8S1810 (http://gdbwww.gdb.org/gdb/). SNP genotyping was performed by fluorescence polarization-based primer extension assay using the relevant AcycloPrime FP SNP detection kit (Perkin-Elmer Life Sciences, Boston, MA, USA), according to the manufacturer's instructions, and an automated allele scoring platform. 22 Microsatellites were typed via standard PCR using one fluorescent dye-labelled primer, followed by electrophoresis on an SCE7610 capillary sequencer (Spectrumedix) and allele-calling using Spectrumedix genotyping software. Genotyping results were examined for incompatibilities within families, by PEDCHECK, 27 and also for unlikely recombinations, by MERLIN. 28 Detection of incompatibilities or unlikely recombinants led to rechecking of genotypes and subsequent correction as necessary.
Statistical analysis
Nonparametric linkage analysis of schizophrenia to NRG1 was performed using MERLIN. 28 MERLIN was first used to calculate allele frequencies for all markers. To determine the haplotypic structure of this region of NRG1 in our sample, we first estimated haplotypes in our pedigrees using Simwalk 2.0. 21 Intermarker LD was calculated using GOLD. 29 Calculation of intermarker distance was performed by BLAST analysis of each marker sequence against the human genome sequence at NCBI (http:// www.ncbi.nlm.nih.org/), and BLAT analysis against the April 2003 human genome assembly via The University of Santa Cruz genome browser (http:// genome.ucsc.edu/).
We performed association analysis using the programs TRANSMIT v2.5.2 19 and FBAT. 20 TRANSMIT implements the Transmission Disequilibrium Test (TDT) by considering vertical transmissions, and is a test for linkage with increased power in the presence of association. FBAT, or the Family Based Association Test, is a test for association in the presence of linkage. FBAT has the advantage over conventional TDT of being able to use data from all family members, not just case-parent trios. The most conservative criteria were chosen for the TRANSMIT runs, that is, one random nuclear family per pedigree, and one random offspring per nuclear family, as multiple nuclear families per pedigree can inflate P-values by picking up linkage for a rare allele. We performed 1000 such runs for each marker/haplotype, using 10 000 bootstraps, and calculated the mean P-value to determine empirical significance. This also removed the bias introduced by variable number of affected individuals per family, which effectively weights families according to the number of affected offspring.
